U.S. Patents Awarded to Inventors in New York (Sept. 1)

Targeted News ServiceTargeted News Service

ALEXANDRIA, Va., Sept. 1 -- The following federal patents were awarded to inventors in New York.

***

General Electric Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- General Electric, Schenectady, N.Y., has been assigned a patent (8,252,091) developed by Ashok Kumar Anand, Niskayuna, N.Y., Chetan Madhav Joshi, Bangalore, India, and Jegadeesan Maruthamuthu, Dindigul, India, for a "CO.sub.2 recovery from IGCC power plants."

The abstract of the patent published by the U.S. Patent and Trademark Office states: "In a system involving CO.sub.2 capture having an acid gas removal system to selectively remove CO.sub.2 from shifted syngas, the acid gas removal system including at least one stage, e.g. a flash tank, for CO.sub.2 removal from an input stream of dissolved carbon dioxide in physical solvent, the method of recovering CO.sub.2 in the acid gas removal system including: elevating a pressure of the stream of dissolved carbon dioxide in physical solvent; and elevating the temperature of the pressurized stream upstream of at least one CO.sub.2 removal stage."

The patent application was filed on March 18, 2008 (12/076,386). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,091.PN.&OS=PN/8,252,091&RS=PN/8,252,091

Written by Shabnam Sheikh; edited by Jaya Anand.

***

Q-Spine Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Q-Spine, New York, has been assigned a patent (8,252,001) developed by seven co-inventors for an "apparatus and methods for inter-operative verification of appropriate spinal prosthesis size and placement." The co-inventors are Martin Quirno, New York, Natalia J. Schmidt, Howell, N.J., Ashley Steimle, Toms River, N.J., Trupti Karkar, Dumont, N.J., Jacqueline K. C. Hilt, Clifton, N.J., Vikki Hazelwood, Wayne, N.J., and Antonio Valdevit, Effort, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A distractor and measuring device includes a first handle operatively connected to a first paddle and a second handle operatively connected to a second paddle. The first and second handles are pivotally connected to one another such that movement of the handles relative to one another causes the paddles to move relative to each other. At least one transducer is positioned on at least one of the first and second handles for measuring an amount of force applied during distraction. A measurement rod is pivotally connected to the device and is movable in a longitudinal direction relative to the first and second paddles. A potentiometer is operatively connected to the measurement rod to measure the angular orientation of the measurement rod."

The patent application was filed on Aug. 27, 2009 (12/549,315). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,001.PN.&OS=PN/8,252,001&RS=PN/8,252,001

Written by Shabnam Sheikh; edited by Jaya Anand.

***

New York University, Research Foundation of the City University of New York Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- New York University, New York, and Research Foundation of the City University of New York, New York, have been Assigned a patent (8,252,909) developed by four co-inventors for a "synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases." The co-inventors are Moriya Tsuji, New York, Guangwu Chen, Corona, N.Y., Richard Franck, Riverside, Conn., and Guangli Yang, Brooklyn, N.Y.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is directed to compounds of formula (I) ##STR00001## wherein X is O or NH; R' is a hydrocarbon chain; R.sup.3 and R.sup.4 are hydrogen, OH or a monosaccharide; R.sup.5 is hydrogen or a monosaccharide; Q' is optionally present and may be a C.sub.1-10 hydrocarbon; X' is optionally present and may be O, S or NR.sup.8; and Q.sup.3 may be a hydrocarbon or hydrogen. The invention is also directed to the use of the compounds for treating cancer, infectious diseases and autoimmune diseases. The invention is also directed to syntheses of the compounds of formula (I)."

The patent application was filed on July 29, 2005 (11/193,852). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,909&OS=8,252,909&RS=8,252,909

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Nestec, Cornell University Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Nestec, Vevey, Switzerland, and Cornell University, Ithaca, N.Y., have been Assigned a patent (8,252,977) developed by five co-inventors for "polynucleotides encoding carotenoid and apocartenoid biosynthetic pathway enzymes in coffee." The co-inventors are Steven D. Tanksley, Dryden, N.Y., Chenwei Lin, Auburndale, Mass., Andrew Simkin, Tours, France, James Gerard McCarthy, Noizay, France, and Vincent Petiard, Tours, France.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Polynucleotides encoding polypeptides that comprise the biosynthetic pathway for carotenoids and apocarotenoids in the coffee plant are disclosed. Also disclosed are a promoter sequence from a coffee carotenoid gene, and methods for using these polynucleotides, polypeptides, and promoter sequences for gene regulation and the manipulation of flavor, aroma, and other features of coffee beans, as well as the manipulation of photosynthesis in the coffee plant."

The patent application was filed on Sept. 1, 2006 (11/990,835). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,977&OS=8,252,977&RS=8,252,977

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Rensselaer Polytechnic Institute Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Rensselaer Polytechnic Institute, Troy, N.Y., has been Assigned a patent (8,252,929) developed by Mark P. Wentland, Watervliet, N.Y., for 8-carboxamido-2,6-methano-3-benzazocines.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is --CH.sub.2--OH, --CH.sub.2NH.sub.2, --NHSO.sub.2CH.sub.3, ##STR00001## and Y is O, S or NOH are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. ##STR00002## 8-Carboxamides, thiocarboxamides, hydroxyamidines and formamides are preferred."

The patent application was filed on May 9, 2011 (13/103,599). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,929&OS=8,252,929&RS=8,252,929

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Honeywell International Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Honeywell International, Morristown, N.J., has been Assigned a patent (8,252,965) developed by Daniel C. Merkel, West Seneca, N.Y., Hsueh Sung Tung, Getzville, N.Y., and Konstantin A. Pokrovski, Williamsville, N.Y., for a "method for separating halocarbons."

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides a method for separating halocarbons. In particular, a method for separating 2-chloro-1,1,1,2-tetrafluoropropane (HCFC-244bb) from 2-chloro-3,3,3-trifluoropropene (HCFO-1233xf) based on differences in melting points of these compounds. More particularly the invention pertains to a method for separating HCFC-244bb from HCFO-1233xf which are useful as intermediates in the production of 2,3,3,3-tetrafluoropropene (HFO-1234yf)."

The patent application was filed on Aug. 12, 2009 (12/540,252). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,965&OS=8,252,965&RS=8,252,965

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Novomer Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Novomer, Ithaca, N.Y., has been Assigned a patent (8,252,891) developed by four co-inventors for purification of polycarbonates. The co-inventors are Anna E. Cherian, Ithaca, N.Y., Jeffrey R. Conuel, Ithaca, N.Y., David E. Decker, Ithaca, N.Y., and Scott D. Allen, Ithaca, N.Y.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure provides, in part, a method for removing a catalyst from a product of catalyzed aliphatic polycarbonate polymerization reaction."

The patent application was filed on May 27, 2005 (13/119,408). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,891&OS=8,252,891&RS=8,252,891

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

New York University Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- New York University, New York, has been assigned a patent (8,252,760) developed by four co-inventors for "compositions and methods for diagnosing and treating melanoma." The co-inventors are Eva Hernando, New York, Miguel F. Segura, New York, Douglas Hanniford, New York, and Silvia Menendez, New York.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom."

The patent application was filed on March 24, 2009 (12/410,348). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,760&OS=8,252,760&RS=8,252,760

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Memory Pharmaceuticals Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Memory Pharmaceuticals, Montvale, N.J., has been Assigned a patent (8,252,811) developed by five co-inventors for "indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof." The co-inventors are Wenge Xie, Mahwah, N.J., Brian Herbert, Stockholm, N.J., Truc Nguyen, New York, Carla Gauss, New York, and Ashok Tehim, Ridgewood, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the .alpha.7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof."

The patent application was filed on Dec. 28, 2011 (13/338,835). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,811&OS=8,252,811&RS=8,252,811

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Bausch & Lomb Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Bausch & Lomb, Rochester, N.Y., has been Assigned a patent (8,252,850) developed by Ivan M. Nunez, Penfield, N.Y., Joseph A. McGee, Canandaigua, N.Y., and David E. Seelye, Williamsville, N.Y., for crosslink agents.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel crosslink agents are described that provide for the copolymerization of at least one hydrophilic monomer with at least one lens monomer typically used to prepare materials for ophthalmic lenses. The new crosslink agents have a relatively high selectivity for the hydrophilic monomer and limited reactivity with the crosslink agent used to polymerize the lens monomer."

The patent application was filed on Jan. 11, 2011 (13/004,228). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,850&OS=8,252,850&RS=8,252,850

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

New York University Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- New York University, New York, has been Assigned a patent (8,252,823) developed by Ramanuj Dasgupta, New York, and Foster Gonsalves, Long Island City, N.Y., for "oxazole and thiazole compounds as beta-catenin modulators and uses thereof."

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of .beta.-cat oxazole and thiazole compounds are disclosed that have a formula represented by the following: ##STR00001## The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others."

The patent application was filed on Jan. 28, 2009 (12/322,070). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,823&OS=8,252,823&RS=8,252,823

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Columbia University Assigned Patent

ALEXANDRIA, Va., Sep. 1 -- Columbia University, New York, has been assigned a patent (8,252,754) developed by four co-inventors for a neuronal pain pathway. The co-inventors are Richard Ambron, Lake Success, N.Y., Ying-Ju Sung, Prospect Park, N.J., Donald W. Landry, New York, and Shi-Xian Deng, White Plains, N.Y.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to the discovery of a novel molecular pathway involved in long-term hyperexcitability of sensory neurons, which, in higher animals, is associated with persistent pain. It is based on the discovery that, following injury to an axon of a neuron, an increase in nitric oxide synthase activity results in increased nitric oxide production, which, in turn, activates guanylyl cyclase, thereby increasing levels of cGMP. Increased cGMP results in activation of protein kinase G ("PKG"), which then is retrogradely transported along the axon to the neuron cell body, where it phosphorylates MAPKerk."

The patent application was filed on March 21, 2006 (11/385,455). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,754.PN.&OS=PN/8,252,754&RS=PN/8,252,754

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Medicis Pharmaceutical Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Medicis Pharmaceutical, Scottsdale, Ariz., has been assigned a patent (8,252,776) developed by four co-inventors for "minocycline oral dosage forms for the treatment of acne." The co-inventors are Mitchell Wortzman, Scottsdale, Ariz., R. Todd Plott, Briscoe, Texas, Kuljit Bhatia, Nesconset, N.Y., and Bhiku Patel, Chandler, Ariz.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne."

The patent application was filed on April 2, 2007 (11/695,513). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,776&OS=8,252,776&RS=8,252,776

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Xerox Assigned Patent for Toner Compositions

ALEXANDRIA, Va., Sept. 1 -- Xerox, Norwalk, Conn., has been assigned a patent (8,252,493) developed by six co-inventors for a toner compositions. The co-inventors are Samir Kumar, Pittsford, N.Y., Grazyna L. Kmiecik-Lawrynowicz, Fairport, N.Y., Maura A. Sweeney, Irondequoit, N.Y., Michael L. Grande, Palmyra, N.Y., Julie C. Pickering, Webster, N.Y., and Timothy L. Lincoln, Rochester, N.Y.The abstract of the patent published by the U.S. Patent and Trademark Office states: "Single component toners are provided with at least one surface additive including a large polymeric spacer, and processes for producing the same. In embodiments, the toner is a non-magnetic single component toner produced by emulsion aggregation methods. The large polymeric spacer additives provide excellent flow characteristics to the resulting toners, and reduce the incidence of clogging failure and print defects such as ghosting, white bands, and low toner density compared with conventionally produced toners."

The patent application was filed on Oct. 15, 2008 (12/251,759). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,493.PN.&OS=PN/8,252,493&RS=PN/8,252,493

Written by Kusum Sangma; edited by Anand Kumar.

***

Corning Assigned Patent for Multi-purpose Substrates Useful for Cell Culture and Methods for Making

ALEXANDRIA, Va., Sept. 1 -- Corning, Corning, N.Y., has been assigned a patent (8,252,549) developed by Hongwei Hanna Rao, Horseheads, N.Y., and Jian Tan, Ithaca, N.Y., for a "multi-purpose substrates useful for cell culture and methods for making."The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are multi-purpose substrates composed of (1) a base coated with a calcium phosphate coating and (2) a fluorophore-labeled collagen adsorbed on the calcium phosphate coating. The multi-purpose substrates are useful in culturing and studying the activity of a variety of cells. The multi-purpose substrates described herein can be used for both solution- and image-based analysis of cultured cells. New methods for producing and using such coated substrates are also disclosed."

The patent application was filed on Nov. 25, 2009 (12/625,952). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,549.PN.&OS=PN/8,252,549&RS=PN/8,252,549

Written by Kusum Sangma; edited by Anand Kumar.

***

Corning Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Corning, Corning, N.Y., has been assigned a patent (8,252,716) developed by Kishor Purushottam Gadkaree, Big Flats, N.Y., and Jia Liu, Painted Post, N.Y., for a "process for making porous activated carbon."The abstract of the patent published by the U.S. Patent and Trademark Office states: "A two-cycle thermal process for making porous activated carbon materials involves a first step of heating a mixture of a carbon precursor/chemical additive in a first heating cycle at a first temperature to cause gas liberation and volumetric expansion of the mixture, and heating the carbon material produced in the first step in a second heating cycle at a second temperature to carbonize and activate the carbon precursor. During the second cycle, essentially no gas liberation or volumetric expansion is observed."

The patent application was filed on Nov. 4, 2008 (12/264,348). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,716.PN.&OS=PN/8,252,716&RS=PN/8,252,716

Written by Kusum Sangma; edited by Anand Kumar.

***

Carestream Health Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Carestream Health, Rochester, N.Y., has been assigned a patent (8,252,617) developed by Timothy J. Tredwell, Fairport, N.Y., for a "continuous large area imaging and display arrays using readout arrays fabricated in silicon-on-glass substrates."The abstract of the patent published by the U.S. Patent and Trademark Office states: "A vertically-integrated image sensor is proposed with the performance characteristics of single crystal silicon but with the area coverage and cost of arrays fabricated on glass. The image sensor can include a backplane array having readout elements implemented in silicon-on-glass, a frontplane array of photosensitive elements vertically integrated above the backplane, and an interconnect layer disposed between the backplane array and the image sensing array. Since large area silicon-on-glass backplanes are formed by tiling thin single-crystal silicon layers cleaved from a thick silicon wafer side-by-side on large area glass gaps between the tiled silicon backplane would normally result in gaps in the image captured by the array. Therefore, embodiments further propose that the pixel pitch in both horizontal and vertical directions of the frontplane be larger than the pixel pitch of the backplane, with the pixel pitch difference being sufficient that the frontplane bridges the gap between backplane tiles."

The patent application was filed on Jan. 25, 2012 (13/357,694). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,617.PN.&OS=PN/8,252,617&RS=PN/8,252,617

Written by Kusum Sangma; edited by Anand Kumar.

***

Eastman Kodak Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Eastman Kodak, Rochester, N.Y., has been assigned a patent (8,252,414) developed by four co-inventors for a "polymer particles with additives encapsulated in microvoids." The co-inventors are David D. Putnam, Fairport, N.Y., Mridula Nair, Penfield, N.Y., Mary C. Brick, Webster, N.Y., and Tamara K. Jones, Rochester, N.Y.The abstract of the patent published by the U.S. Patent and Trademark Office states: "Porous particles comprising a polymer binder and at least one additive distinct from any pore stabilizing compound present in the particle, wherein: the polymer binder comprises a solid compositionally continuous phase having an external particle surface; discrete pores are dispersed within the solid compositionally continuous phase, forming internal pore surfaces; and the at least one additive is present primarily in the discrete pores. The additive may further preferably not be present in the solid compositionally continuous phase, and be substantially absent from the external particle surface. A toner set for forming a color electrophotographic image comprising a plurality of different colored toners, where at least one of the different colored toners comprise such porous particles comprising additives, and in a particular embodiment wherein at least two different colored toners each comprise different pigments present primarily in the internal pores. A process of making such porous particles."

The patent application was filed on July 20, 2009 (12/505,757). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,414.PN.&OS=PN/8,252,414&RS=PN/8,252,414

Written by Kusum Sangma; edited by Anand Kumar.

***

International Paper Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- International Paper, Memphis, Tenn., has been assigned a patent (8,252,373) developed by Jay C. Song, Highland Mills, N.Y., and Sen Yang, Nanuet, N.Y., for a "gloss coated multifunctional printing paper."The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to a gloss coated multifunctional printing paper that can be used with a variety of office printing equipment including inkjet and electrophotographic and to processes of making and using the paper, a paper substrate; and a pigmented composition coated on at least one surface of the substrate, said pigmented coating composition comprising (1) a first pigment having a BET surface area in the range of from about 50 to about 750 m.sup.2/g; (2) a second pigment having a BET surface area in the range of from about 5 to about 49 m.sup.2/g; and (3) a polymeric binder. Said coated paper having a coating gloss equal to or greater than about 30% at 75.degree. and a Bristow Absorption length of less than about 180 mm. The coating compositions may contain other additives such as lubricants, optical brighteners and coating rheology modifiers. The coating formulations can be applied to the base stock using any of a large number of coating techniques including application roll with bent blade, rod, air knife, slot die, curtain spray and gravure. The paper can be used with various inkjet and electrophotographic printing apparatus and techniques."

The patent application was filed on June 30, 2010 (12/826,734). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,373.PN.&OS=PN/8,252,373&RS=PN/8,252,373

Written by Kusum Sangma; edited by Anand Kumar.

***

Ludwig Institute for Cancer Research Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Ludwig Institute for Cancer Research, New York, has been Assigned a patent (8,252,903) developed by four co-inventors for human sarcoma-associated antigens. The co-inventors are Matthew J. Scanlan, Princeton Junction, N.J., Cynthia H. Scanlan legal representative, Princeton Junction, N.J., Sang-Yull Lee, New York, and Lloyd J. Old, New York.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35."

The patent application was filed on Jan. 6, 2010 (12/683,374). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,252,903&OS=8,252,903&RS=8,252,903

Written by Satyaban Rath; edited by Hemanta Panigrahi.

***

Research Foundation of State University of New York Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Research Foundation of State University of New York, Amherst, N.Y., has been assigned a patent (8,252,527) developed by John M. Sullivan, Hamburg, N.Y., and Edwin H. Yau, Amherst, N.Y., for a "method for identification of polynucleotides capable of cleaving target mRNA sequences."The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are methods for identifying a polynucleotide that can reduce the level of a target mRNA. The method can be performed by providing cells that express an RNA polynucleotide that contains a target mRNA sequence, an internal ribosome entry sequence (IRES) and a sequence encoding a secreted reporter protein; introducing to the cells a test polynucleotide, and measuring activity of the secreted reporter protein. A reduction in secreted reporter protein activity relative to a control cell into which the test polynucleotide has not been introduced is indicative that the test polynucleotide is capable of reducing the level of the target mRNA in the cells. The method is adaptable for high throughput screening methods and is suited for identifying polynucleotides that can catalyze cleavage of target mRNA and/or act on target mRNA through and antisense or RNAi mechanism."

The patent application was filed on Feb. 19, 2008 (12/070,561). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,527.PN.&OS=PN/8,252,527&RS=PN/8,252,527

Written by Kusum Sangma; edited by Anand Kumar.

***

GM Global Technology Operations Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- GM Global Technology Operations, Detroit, has been assigned a patent (8,252,712) developed by four co-inventors for a "polymer dispersant addition to fuel cell electrode inks for improved manufacturability." The co-inventors are Roland J. Koestner, Penfield, N.Y., Sean M. Mackinnon, Fairport, N.Y., Timothy J. Fuller, Pittsford, N.Y., and Jeanette E. Owejan, Honeoye, N.Y.The abstract of the patent published by the U.S. Patent and Trademark Office states: "An ink composition for forming a fuel cell electrode includes a catalyst composition, a polymeric binder, a polymeric dispersant, and a solvent. The polymeric dispersant includes a perfluorocyclobutyl-containing polymer."

The patent application was filed on Nov. 13, 2009 (12/551,237). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,712.PN.&OS=PN/8,252,712&RS=PN/8,252,712

Written by Kusum Sangma; edited by Anand Kumar.

***

Corning Assigned Patent for Crystallization-free Glass Frit Compositions and Frits Made Therefrom for Microreactor Devices

ALEXANDRIA, Va., Sept. 1 -- Corning, Corning, N.Y., has been assigned a patent (8,252,708) developed by Robert Michael Morena, Lindley, N.Y., Paulo Jorge Marques, Fontainebleau, France, and Henry Edwin Hagy, Painted Post, N.Y., for a "crystallization-free glass frit compositions and frits made therefrom for microreactor devices."The abstract of the patent published by the U.S. Patent and Trademark Office states: "A borosilicate glass composition suitable for manufacturing microreactor glass frits includes 12-22 mol % B.sub.2O.sub.3=12-22; 68-80 mol % SiO.sub.2; 3-8 mol % Al.sub.2O.sub.3, 1-8 mol % Li.sub.2O, and one of 0.5.+-.0.1 mol % ZrO.sub.2 and 1.1.+-.0.5 mol % F. After sintering a glass frit having the borosilicate glass composition, the glass frit has a surface crystalline layer of 30 .mu.m or less or is amorphous throughout."

The patent application was filed on March 8, 2012 (13/415,286). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,708.PN.&OS=PN/8,252,708&RS=PN/8,252,708

Written by Kusum Sangma; edited by Anand Kumar.

***

Bio-Botanica Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Bio-Botanica, Hauppauge, N.Y., has been assigned a patent (8,252,347) developed by Frank S. D'Amelio Sr., Cold Spring Harbor, N.Y., for "stabilizing and antioxidant composition containing saw palmetto berry component and method of use."The abstract of the patent published by the U.S. Patent and Trademark Office states: "A stabilizing and antioxidant composition is prepared from the residue obtained from the saw palmetto berry. The residue from the saw palmetto berry exhibits antioxidant properties that can be used to stabilize various compositions such as food or edible compositions and cosmetics. The saw palmetto residue is also delivered topically or orally to a patient to administer an effective amount of an antioxidant to a patient."

The patent application was filed on Nov. 30, 2006 (11/606,352). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,347.PN.&OS=PN/8,252,347&RS=PN/8,252,347

Written by Kusum Sangma; edited by Anand Kumar.

***

Unigene Laboratories Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Unigene Laboratories, Boonton, N.J., has been assigned a patent (8,252,580) developed by four co-inventors for a "bacterial host cell for the direct expression of peptides." The co-inventors are Nozer M. Mehta, Randolph, N.J., Angelo P. Consalvo, Monroe, N.Y., Martha V.L. Ray, Nutley, N.J., and Christopher P. Meenan, Lincoln Park, N.J.The abstract of the patent published by the U.S. Patent and Trademark Office states: "Expression systems are disclosed for the direct expression of peptide products into the culture media where genetically engineered host cells are grown. High yield was achieved with a special selection of hosts, and/or fermentation processes which include careful control of cell growth rate, and use of an inducer during growth phase. Special universal cloning vectors are provided for the preparation of expression vectors which include control regions having multiple promoters linked operably with coding regions encoding a signal peptide upstream from a coding region encoding the peptide of interest. Multiple transcription cassettes are also used to increase yield. The production of amidated peptides using the expression systems is also disclosed."

The patent application was filed on October 30, 2007 (11/928,994). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,580.PN.&OS=PN/8,252,580&RS=PN/8,252,580

Written by Kusum Sangma; edited by Anand Kumar.

***

General Electric Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- General Electric, Niskayuna, N.Y., has been assigned a patent (8,252,613) developed by four co-inventors for a "color stable manganese-doped phosphors." The co-inventors are Robert Joseph Lyons, Burnt Hills, N.Y., Anant Achyut Setlur, Niskayuna, N.Y., Anirudha Rajendra Deshpande, Twinsburg, Ohio, and Ljudmil Slavchev Grigorov, Sofia, Bulgaria.The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for preparing color stable Mn.sup.+4 doped phosphors includes providing a phosphor of formula I; A.sub.x[MF.sub.y]:Mn.sup.+4 I and contacting the phosphor in particulate form with a saturated solution of a composition of formula II in aqueous hydrofluoric acid; A.sub.x[MF.sub.y]; II wherein A is Li, Na, K, Rb, Cs, NR.sub.4 or a combination thereof; M is Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Y, La, Nb, Ta, Bi, Gd, or a combination thereof; R is H, lower alkyl, or a combination thereof; x is the absolute value of the charge of the [MF.sub.y] ion; and y is 5, 6 or 7. In particular embodiments, M is Si, Ge, Sn, Ti, Zr, or a combination thereof. A lighting apparatus capable of emitting white light includes a semiconductor light source; and a phosphor composition radiationally coupled to the light source, and which includes a color stable Mn.sup.+4 doped phosphor."

The patent application was filed on March 23, 2011 (13/069,756). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,613.PN.&OS=PN/8,252,613&RS=PN/8,252,613

Written by Kusum Sangma; edited by Anand Kumar.

***

Xerox Assigned Patent for Polyamideimide Polybenzimidazole Containing Intermediate Transfer Members

ALEXANDRIA, Va., Sept. 1 -- Xerox, Norwalk, Conn., has been assigned a patent (8,252,420) developed by four co-inventors for a "polyamideimide polybenzimidazole containing intermediate transfer members." The co-inventors are Jin Wu, Pittsford, N.Y., Dante M. Pietrantoni, Rochester, N.Y., Yuhua Tong, Webster, N.Y., and Jonathan H. Herko, Walworth, N.Y.The abstract of the patent published by the U.S. Patent and Trademark Office states: "An intermediate transfer member that includes a mixture of a polyamideimide, a polybenzimidazole, and an optional conductive filler."

The patent application was filed on Jan. 18, 2011 (13/008,201). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,420.PN.&OS=PN/8,252,420&RS=PN/8,252,420

Written by Kusum Sangma; edited by Anand Kumar.

***

Memorial Sloan-Kettering Cancer Center Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Memorial Sloan-Kettering Cancer Center, New York, has been assigned a patent (8,252,592) developed by Michel Sadelain, New York, and Matthias Stephan, Boston, for a "constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes."The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressing at least one of an antigen-recognizing receptor and a co-stimulatory ligand and methods of use therefore for the treatment of neoplasia and other pathologies where an increase in an antigen-specific immune response is desired."

The patent application was filed on March 31, 2008 (12/593,751). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,592.PN.&OS=PN/8,252,592&RS=PN/8,252,592

Written by Kusum Sangma; edited by Anand Kumar.

***

California Institute of Technology Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- California Institute of Technology, Pasadena, Calif., has been assigned a patent (8,252,559) developed by Rudi Fasan, Rochester, N.Y., and Frances H. Arnold, La Canada, Calif., for "methods and systems for selective fluorination of organic molecules."The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system for selectively fluorinating organic molecules on a target site wherein the target site is activated and then fluorinated are shown together with a method and system for identifying a molecule having a biological activity."

The patent application was filed on Feb. 4, 2009 (12/365,884). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,559.PN.&OS=PN/8,252,559&RS=PN/8,252,559

Written by Kusum Sangma; edited by Anand Kumar.

***

Micron Technology Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Micron Technology, Boise, Idaho, has been assigned a patent (8,252,697) developed by Kie Y. Ahn, Chappaqua, N.Y., and Leonard Forbes, Corvallis, Ore., for a "zinc-tin oxide thin-film transistors."The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods of forming transparent zinc-tin oxide structures are described. Devices that include transparent zinc-tin oxide structures as at least one of a channel layer in a transistor or a transparent film disposed over an electrical device that is at a substrate."

The patent application was filed on May 14, 2007 (11/803,261). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,697.PN.&OS=PN/8,252,697&RS=PN/8,252,697

Written by Kusum Sangma; edited by Anand Kumar.

***

International Business Machines Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- International Business Machines, Armonk, N.Y., has been assigned a patent (8,252,673) developed by four co-inventors for a "spin-on formulation and method for stripping an ion implanted photoresist." The co-inventors are Ali Afzali-Ardakani, Yorktown Heights, N.Y., Mahmoud Khojasteh, Yorktown Heights, N.Y., Ronald W. Nunes, Yorktown Heights, N.Y., and George G. Totir, Yorktown Heights, N.Y.The abstract of the patent published by the U.S. Patent and Trademark Office states: "A spin-on formulation that is useful in stripping an ion implanted photoresist is provided that includes an aqueous solution of a water soluble polymer containing at least one acidic functional group, and at least one lanthanide metal-containing oxidant. The spin-on formulation is applied to an ion implanted photoresist and baked to form a modified photoresist. The modified photoresist is soluble in aqueous, acid or organic solvents. As such one of the aforementioned solvents can be used to completely strip the ion implanted photoresist as well as any photoresist residue that may be present. A rinse step can follow the stripping of the modified photoresist."

The patent application was filed on Dec. 21, 2009 (12/643,454). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,673.PN.&OS=PN/8,252,673&RS=PN/8,252,673

Written by Kusum Sangma; edited by Anand Kumar.

***

Rich Products Assigned Patent

ALEXANDRIA, Va., Sept. 1 -- Rich Products, Buffalo, N.Y., has been assigned a patent (8,252,358) developed by Michael Piatko, West Seneca, N.Y., and Cheryl Perks, Ridgeway, Canada, for a "stable Protein-free whippable food product."The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a substantially protein-free whippable food product having improved stability characteristics without detectable change in the organoleptic characteristics. The product comprises triglyceride fat, one or more sugars, an emulsifier component, a starch component comprising one or more NOSA starches and one or more hydrophilic starches, and optionally an acid component. This product can be stored frozen or at ambient temperatures for extended periods of time and can also be whipped and displayed at ambient temperatures."

The patent application was filed on Oct. 5, 2007 (11/868,166). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,252,358.PN.&OS=PN/8,252,358&RS=PN/8,252,358

Written by Kusum Sangma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1098423